Literature DB >> 23494413

Changes in the gene expression pattern induced by 2-methoxyestradiol in the mouse uterus.

Ramiro J Rincón-Rodríguez1, María L Oróstica, Patricia Díaz, Patricia Reuquén, Hugo Cárdenas, Pedro A Orihuela.   

Abstract

2-Methoxyestradiol (2ME) is an estrogen metabolite with antitumor and antiangiogenic properties, although their effects on the reproductive tissues are not well-determined. Furthermore, it is not very clear whether 2ME is part of the intracellular signaling of estradiol (E2) or it acts through other signaling pathways. The purpose of this study was to determine changes in the gene expression pattern in the mouse female reproductive tract induced by 2ME, under conditions in which this metabolite has no estrogenic activity. Therefore, we first compared the effect of 2ME or E2 on the uterine weight and epithelial cell height, and on the ovarian weight and the number of follicles of immature mice. Then, we examined the gene expression profile in the uterus of immature mice treated with 2ME or E2 and we selected three genes scd2, snx6, and spon1, to confirm differential regulation by E2 and 2ME in the uterine cells using real-time PCR. Finally, in order to explore the physiologic relevance of the 2ME-induced genes we determined the expression and localization of the F-spondin protein encoded by spon1 in the uterus of mature mice treated with E2 or 2ME. Estradiol and 2ME reduced the ovarian weight and decreased the number of follicles ≥ 300 μm, whereas E2 increased the uterine weight and epithelial cell height but not 2ME, indicating that 2ME did not have estrogenic activity in the mouse uterus. Microarray analysis showed that 1.8 % of the uterine genes were regulated by E2 and 0.23 % by 2ME, while 0.04 % was regulated by E2 and 2ME. The mRNA for scd2 was exclusively increased by 2ME, whereas snx6 and spon1 were up-regulated by E2 and 2ME, but the response to 2ME was more intense. F-spondin was mainly expressed in the uterine stroma layer although 2ME or E2 did not change its localization in the uterine cells. We conclude that 2ME regulates a group of genes in the mice uterus, independently of estrogenic activity, suggesting a functional involvement of 2ME in the mammalian uterus.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494413     DOI: 10.1007/s12020-013-9921-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  35 in total

1.  Importance of A-ring substitution of estrogens for the physiology and pharmacology of reproduction.

Authors:  R Knuppen; P Ball; G Emons
Journal:  J Steroid Biochem       Date:  1986-01       Impact factor: 4.292

2.  Isolation and identification of F-spondin in the boar testis and its production during testis growth.

Authors:  Katsuhiko Ohnuma; Hiroyuki Kaneko; Junko Noguchi; Kazuhiro Kikuchi; Manabu Ozawa; Yoshihisa Hasegawa
Journal:  J Reprod Dev       Date:  2006-10-14       Impact factor: 2.214

3.  Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus.

Authors:  W Ma; J Tan; H Matsumoto; B Robert; D R Abrahamson; S K Das; S K Dey
Journal:  Mol Endocrinol       Date:  2001-11

4.  Estrogen 2-, 4-, 6- or 16-hydroxylation by human follicles shown by gas chromatography-mass spectrometry associated with stable isotope dilution.

Authors:  L Dehennin; C Blacker; A Reiffsteck; R Scholler
Journal:  J Steroid Biochem       Date:  1984-01       Impact factor: 4.292

Review 5.  Functional role of estrogen metabolism in target cells: review and perspectives.

Authors:  B T Zhu; A H Conney
Journal:  Carcinogenesis       Date:  1998-01       Impact factor: 4.944

6.  TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract.

Authors:  Anil Sadarangani; Sumie Kato; Natalia Espinoza; Soledad Lange; Carmen Llados; Marisol Espinosa; Manuel Villalón; Stanley Lipkowitz; Mauricio Cuello; Gareth I Owen
Journal:  Apoptosis       Date:  2007-01       Impact factor: 4.677

7.  2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

Authors:  Nicola J Mabjeesh; Daniel Escuin; Theresa M LaVallee; Victor S Pribluda; Glenn M Swartz; Michelle S Johnson; Margaret T Willard; Hua Zhong; Jonathan W Simons; Paraskevi Giannakakou
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

8.  Estrogen metabolites in equine ovarian follicles: gas chromatographic-mass spectrometric determinations in relation to follicular ultrastructure and progestin content.

Authors:  P Silberzahn; G Almahbobi; L Dehennin; A Merouane
Journal:  J Steroid Biochem       Date:  1985-04       Impact factor: 4.292

9.  Catechol-o-methyltransferase and methoxyestradiols participate in the intraoviductal nongenomic pathway through which estradiol accelerates egg transport in cycling rats.

Authors:  Alexis Parada-Bustamante; Pedro A Orihuela; Mariana Ríos; Patricia A Navarrete-Gómez; Catherina A Cuevas; Luis A Velasquez; Manuel J Villalón; Horacio B Croxatto
Journal:  Biol Reprod       Date:  2007-08-15       Impact factor: 4.285

10.  Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.

Authors:  R T Turner; G L Evans; J M Cavolina; B Halloran; E Morey-Holton
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736

View more
  1 in total

1.  Effects of oral exposure to bisphenol A on gene expression and global genomic DNA methylation in the prostate, female mammary gland, and uterus of NCTR Sprague-Dawley rats.

Authors:  Luísa Camacho; Mallikarjuna S Basavarajappa; Ching-Wei Chang; Tao Han; Tetyana Kobets; Igor Koturbash; Gordon Surratt; Sherry M Lewis; Michelle M Vanlandingham; James C Fuscoe; Gonçalo Gamboa da Costa; Igor P Pogribny; K Barry Delclos
Journal:  Food Chem Toxicol       Date:  2015-04-08       Impact factor: 6.023

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.